Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $341.14M.
ENTERPRISE VALUE (EV)
$341.14M
Artiva Biotherapeutics, Inc.
Market Cap
$356.90M
Enterprise Value (EV)
$341.14M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $356.90M | $341.14M |
| Ocugen, Inc. (OCGN)vs › | $356.88M | $344.81M |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.11M | $379.35M |
| Viemed Healthcare, Inc. (VMD)vs › | $356.54M | $357.46M |
| Embecta Corp. (EMBC)vs › | $357.45M | $1.64B |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.35M | $318.11M |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $351.80M | $402.09M |
| Turn Therapeutics Inc. (TTRX)vs › | $350.53M | $346.36M |
| Opus Genetics, Inc. (IRD)vs › | $365.88M | $312.00M |
| Relmada Therapeutics, Inc. (RLMD)vs › | $346.66M | $335.33M |
Market Cap
$356.90M
Total Debt
$10.94M
Cash
$26.70M
Enterprise Value
$341.14M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
